Article Details
Retrieved on: 2021-05-10 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ficlatuzumab is AVEO's potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor (HGF). The study was ...
Article found on: financialpost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here